Dr. Abdurahman Alghabban

Speaker

Day: Day 1

Time: 8:50am – 9:00am

Final Overall Survival Analysis Among Patients With FRα-Positive, Platinum-Resistant Ovarian Cancer (PROC)
Treated With Mirvetuximab Soravtansine (MIRV) vs Investigator’s Choice Chemotherapy (ICC) in the Phase 3 MIRASOL (GOG 3045/ENGOT-ov55) Study

About us

We are delighted to welcome you to the Saudi Gynecological Oncology Congress 2026, which will be held from 25 to 26 Sept 2026 at the Crowne Plaza RDC Riyadh, Kingdom of Saudi Arabia. Alfaisal University organizes this event, which is a must-attend platform for research, collaboration, and clinical excellence in gynecologic oncology.

Useful Links

Congress Location

Riyadh City at the Crowne Plaza RDC Riyadh from 25 to 26 Sept 2026.

About us

Useful Links

Congress Location

© 2026 Saudi Gynecological Oncology Congress & the Society of Gynecologic Oncology 2026 Select. All Rights Reserved